Skip to main content

Icon Legend
Presentation Icons
Ticketed Event
Ticketed Event
In Person Only
In Person Only
Location: Hilton San Diego Bayfront
Location: Hilton San Diego Bayfront

Abstracts

Abstracts

  • Monday, October 2, 2023
  • 8:10 AM – 8:17 AM PT
    134 - Cell-Free DNA Fragmentomics for Early Detection of Malignant Transformation in NF1 Patients Harboring Plexiform Neurofibromas
    Location: Room 4

    Presenter: Aadel Chaudhuri, MD, PhD – Washington University in St. Louis

  • 8:20 AM – 8:27 AM PT
    135 - Proteogenomic Analysis of Human Uterine Cervical Cancer (UCC) Reveals Treatment-Resistant Subtypes of UCC
    Location: Room 4

    Presenter: Joo-Young Kim, MD, PhD – National Cancer Center

  • 8:30 AM – 8:37 AM PT
    136 - Prognostic Significance of Pretreatment Immune Cell Infiltration in Muscle Invasive Bladder Cancer Treated with Definitive Chemoradiation: Analysis of NRG RTOG 0524 and 0712
    Location: Room 4

    Presenter: Matthew Deek, MD – Rutgers University

  • 8:40 AM – 8:47 AM PT
    137 - Concurrent Radiation and Immunotherapy Augments Local Immunity and Improves Survival in Aneuploid NSCLC
    Location: Room 4

    Presenter: Liam Spurr, BS – University of Chicago Pritzker School of Medicine

  • 8:50 AM – 8:57 AM PT
    138 - Comprehensive Genomic Analysis Stratified by KRAS Status in Patients with Pancreatic Adenocarcinoma and Its Prognostic Significance
    Location: Room 4

    Presenter: Jongmyung Kim, MD, PhD – Rutgers Cancer Institute of New Jersey

  • 8:05 AM – 8:10 AM PT
    1024 - Synthetic MRI-Assisted and Self-Supervised Adaptive Segmentation of Organs-at-Risk (OARs) in MRI-Based Radiation Therapy
    Location: Room 8

    Presenter: Reza Kalantar, PhD, MS, BS – The Institute of Cancer Research

  • 8:10 AM – 8:15 AM PT
    1026 - Crowdsourcing Deep Learning Algorithms to Automatically Contour GI Luminal Organs on Serial MRIs
    Location: Room 8

    Presenter: Sangjune Lee, MD, MS, BS, FRCPC DABR – University of Calgary

  • 8:15 AM – 8:20 AM PT
    1028 - Contouring Analysis on Synthetic Contrast-Enhanced MR from GRMM-GAN and Implications on MR-Guide Radiation Therapy
    Location: Room 8

    Presenter: Wensha Yang, PhD – University of California San Francisco

  • 8:20 AM – 8:25 AM PT
    1030 - Deep Learning-Based Pipeline for Automatic Identification of Intestinal Regenerating Crypts in Mouse Histological Images
    Location: Room 8

    Presenter: Jie Fu, PhD – University of Washington

  • 8:25 AM – 8:30 AM PT
    1032 - Towards Automated Dosimetric Analysis of the Bladder Trigone: Deep-Learning-Based Joint Segmentation and Landmark Localization
    Location: Room 8

    Presenter: Hengjie Liu, BS – UCLA

  • 8:30 AM – 8:35 AM PT
    1034 - Organ Specific Deep Learning-Based Correction of Inaccurate Auto-Segmentation on Abdominal MRI
    Location: Room 8

    Presenter: Christina Sarosiek, PhD – Medical College of Wisconsin

  • 10:50 AM – 10:55 AM PT
    1048 - A Prospective Study Evaluating Sexual Health Outcomes in Patients Undergoing (Chemo)Radiation (CRT/RT) for Human Papillomavirus-Associated Oropharyngeal Cancer (HPVOPC)
    Location: Room 7

    Presenter: Lachlan Joseph McDowell, MB, BS, MBBS, FRANZCR – Princess Alexandra Hospital

  • 10:55 AM – 11:00 AM PT
    1050 - Patient-Reported Outcomes Evaluating the Impact of Hypo-Fractionated Palliative Quadshot Radiotherapy and Concurrent CDDP Treatment on Health-Related Quality of Life in Patients with Locally Advanced
    Location: Room 7

    Presenter: Jhansi Pattanaik, MD, MBBS – All India Institute of Medical Sciences

  • 11:00 AM – 11:05 AM PT
    1052 - Hearing Outcomes in Cisplatin or Cetuximab Combined with Radiation for Patients with HPV-Associated Oropharyngeal Cancer in NRG/RTOG 1016
    Location: Room 7

    Presenter: Christina Runge, PhD – Medical College of Wisconsin

  • 11:05 AM – 11:10 AM PT
    1054 - Natural History and Clinical/Dosimetric Determinants of Osteoradionecrosis in a Large Cohort of Head and Neck Cancer Following Curative Radiotherapy: Debunking the Myth of Decreased Rates of Osteoradi
    Location: Room 7

    Presenter: Abdallah Mohamed, MD, PhD – MD Anderson Cancer Center

  • 11:10 AM – 11:15 AM PT
    1056 - Long-Term Outcomes of De-Intensified Chemoradiotherapy for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma
    Location: Room 7

    Presenter: Ryan Morse, MD – University of North Carolina at Chapel Hill

  • 11:15 AM – 11:20 AM PT
    1058 - Brachial Plexus Tolerance to Standard Fractionation Re-Irradiation: The Ohio State University Experience
    Location: Room 7

    Presenter: Khaled Dibs, MD – The James Cancer Hospital & Solove Research Institute

  • 10:55 AM – 11:00 AM PT
    1038 - TFAM Modulates Cardiomyocytes Pyroptosis Induced by Ionizing Radiation through mtDNA/TLR9/NF-kB Pathway
    Location: Room 8

    Presenter: Guoxin Cai, MD – Shandong Cancer Hospital and Institute

  • 11:00 AM – 11:05 AM PT
    1042 - Single-Cell RNA Sequencing Reveals a Subset of cMAS can Aggravate RIHD through CXCL1-CXCR2 Axis
    Location: Room 8

    Presenter: Dawei Chen, MD, MB

  • 11:05 AM – 11:10 AM PT
    1044 - HPK1 Inhibition Enhances HXRT Anti-Tumor Immune Response by Regulating RGS16 to Restore Functionality in Tumor-Infiltrating Exhausted CD8+T Cells
    Location: Room 8

    Presenter: Dawei Chen, MD, MB

  • 11:10 AM – 11:15 AM PT
    1046 - Bifunctional Role of Monocyte Subsets in Modulating Radiotherapy Combined Intra-Tumor aCD40 Agonist Induced Abscopal Effect
    Location: Room 8

    Presenter: Yue Zhao, MD, PhD – China

  • 10:45 AM – 10:52 AM PT
    151 - Dosimetry Reconstruction in Radiopharmaceutical Therapy Using a Sparse Network of External ?-Sensors
    Location: Room 30 A/B/C

    Presenter: Rahul Lall, BS – University of California, Berkeley

  • 10:55 AM – 11:02 AM PT
    152 - Long-Term Results of a Multi-Institutional Study of Dynamic Tumor Tracking-Stereotactic Body Radiotherapy for Lung Tumors
    Location: Room 30 A/B/C

    Presenter: Yukinori Matsuo, MD, PhD – Kindai University Faculty of Medicine

  • 11:05 AM – 11:12 AM PT
    153 - Assessment of Dynamic Contrast Enhanced (DCE) MRI for Detection of Radiotherapy Induced Alteration in Mandibular Vasculature
    Location: Room 30 A/B/C

    Presenter: Moamen Abobakr, MD – MD Anderson Cancer Center

  • 11:15 AM – 11:22 AM PT
    154 - Theranostic Nanoparticle Uptake in Patient Brain Tumors as Quantified by MP2RAGE T1 Mapping
    Location: Room 30 A/B/C

    Presenter: Stephanie Bennett, PhD – Massachusetts General Brigham

  • 11:25 AM – 11:32 AM PT
    155 - The Microvascular Health Status Predicts Radio-Induced Acute Toxicities in Breast, Prostate and Head and Neck Cancer Patients
    Location: Room 30 A/B/C

    Presenter: Tiziana Rancati, MS – Fondazione IRCCS - Istituto Nazionale dei Tumori

  • 11:35 AM – 11:42 AM PT
    156 - Auto-Correction for Inaccurate Auto-Segmentation of Abdominal MRI by Combining Deep Learning and Active Contour Method
    Location: Room 30 A/B/C

    Presenter: Mohammad Zarenia, PhD – Medical College of Wisconsin

  • 10:45 AM – 10:52 AM PT
    145 - Prospective Phase II Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy (SBRT) Followed By Concurrent Mediastinal Chemoradiation and Adjuvant Immunotherapy for Locally-Advanced Non-Small
    Location: Room 6 D/E

    Presenter: John Heinzerling, MD, OCN – Southeast Radiation Oncology Group PA

  • 10:55 AM – 11:02 AM PT
    146 - Adaptive Radiotherapy Guided by PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Phase II Randomized Study
    Location: Room 6 D/E

    Presenter: Yaoyao Zhu, MS, RT – Shanghai Pulmonary Hospital

  • 10:55 AM – 11:02 AM PT
    146 - Adaptive Radiotherapy Guided by PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Phase II Randomized Study
    Location: Room 6 D/E

    Presenter: Yaping Xu, PhD – Shanghai Pulmonary Hospital

  • 11:05 AM – 11:12 AM PT
    147 - Assessment of Precision Irradiation in Early Non-Small Cell Lung Cancer and Interstitial Lung Disease (ASPIRE-ILD): Primary Analysis of a Phase II Trial
    Location: Room 6 D/E

    Presenter: David Palma, MD, PhD – London Health Sciences Centre

  • 11:15 AM – 11:22 AM PT
    148 - Dosimetric Impact of Systematic Mediastinal Staging via Endobronchial Ultrasound for Patients with Locally Advanced Lung Cancer: The SEISMIC Trial
    Location: Room 6 D/E

    Presenter: Shankar Siva, PhD, MBBS, FRANZCR – Peter MacCallum Cancer Centre

  • 11:25 AM – 11:32 AM PT
    149 - Circulating Tumor DNA for Early Risk Stratification of Oligometastatic Lung Cancer
    Location: Room 6 D/E

    Presenter: Aadel Chaudhuri, MD, PhD – Washington University in St. Louis

  • 11:35 AM – 11:42 AM PT
    150 - Residual ctDNA Detection Predicts Benefit From Definitive Chemoradiotherapy and Immune Checkpoint Inhibitors in Locally Advanced NSCLC
    Location: Room 6 D/E

    Presenter: Yu Wang, MD – Chinese Academy of Medical Sciences and Peking Union Medical College

  • 11:45 AM – 11:55 AM PT
    Discussant
    Location: Room 6 D/E

    Discussant: Jeffrey Bradley, MD, FASTRO – University of Pennsvania Radiation Oncology

  • 10:45 AM – 10:52 AM PT
    139 - Quality of Life Results of Addition of Androgen Deprivation Therapy and Pelvic Lymph Node Treatment to Prostate Bed Salvage Radiotherapy: NRG Oncology/RTOG 0534 SPPORT
    Location: Room 6 C/F

    Presenter: Deborah Bruner, PhD, RN, FAAN – Nell Hodgson Woodruff School of Nursing

  • 10:45 AM – 12:00 PM PT
    Discussant
    Location: Room 6 C/F

    Discussant: Cynthia Menard, MD – University of Montreal Hospital (CHUM)

  • 10:55 AM – 11:02 AM PT
    140 - Final Analysis of a Phase III Controlled Randomized Study of Stereotactic Body Proton Therapy or Conventionally Fractionated Proton Therapy for Early Prostate Cancer: PCG GU002
    Location: Room 6 C/F

    Presenter: Diego Toesca, MD – Mayo Clinic Arizona

  • 11:05 AM – 11:12 AM PT
    141 - Conventional vs. Hypo-Fractionated, Radiotherapy for High-Risk Prostate Cancer (PCS5), Randomized, Non-Inferiority, Phase 3 Trial: Posthoc Analysis of IMRT vs. 3D-CRT Radiation Therapy Associated Toxi
    Location: Room 6 C/F

    Presenter: Constanza Martinez, MD, PhD – McGill University Health Centre

  • 11:15 AM – 11:22 AM PT
    142 - Phase III Study of Hypofractionated, Dose Escalation Radiotherapy vs. Conventional Pelvic Radiation Therapy followed by High Dose Rate Brachytherapy Boost for High Risk Adenocarcinoma of the Prostate
    Location: Room 6 C/F

    Presenter: Tamim Niazi, MD – McGill University

  • 11:25 AM – 11:32 AM PT
    143 - Progression-Directed Therapy in Oligoprogressive Castration-Refractory Prostate Cancer: Results of the Prospective Single-Arm Phase II MEDCARE Trial
    Location: Room 6 C/F

    Presenter: Gert De Meerleer, MD, PhD – UZ Leuven

  • 11:35 AM – 11:42 AM PT
    144 - The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B Study
    Location: Room 6 C/F

    Presenter: Ragu Ratnakumaran, MBBS – Royal Marsden NHS Foundation Trust

  • 1:30 PM – 1:40 PM PT
    LBA 04 - Primary Endpoint Results of NRG CC003: Phase IIR/III Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC)
    Location: Ballroom 20

    Presenter: Vinai Gondi, MD – Northwestern Medicine Cancer Center Warrenville and Proton Center

  • 1:40 PM – 1:50 PM PT
    Discussant
    Location: Ballroom 20

    Discussant: Debra Yeboa, MD – MD Anderson Cancer Center

  • 1:50 PM – 2:00 PM PT
    1 - High Dose Hyperfractionated Thoracic Radiotherapy vs. Standard Dose for Limited Stage Small-Cell Lung Cancer: A Multicenter, Open-Label Randomized, Phase 3 Trial
    Location: Ballroom 20

    Presenter: Jiayi Yu, PhD – Peking University Cancer Hospital and Institute

  • 2:00 PM – 2:10 PM PT
    Discussant
    Location: Ballroom 20

    Discussant: Kristin Higgins, MD – Winship Cancer Institute of Emory University

  • 2:10 PM – 2:20 PM PT
    LBA 03 - 5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Fractionated or Moderately Hypo Fractionated Exte
    Location: Ballroom 20

    Presenter: Nicholas van As, MD, MB – The Royal Marsden NHS Foundation Trust

  • 2:20 PM – 2:30 PM PT
    Discussant
    Location: Ballroom 20

    Discussant: Alejandro Berlin, MD, MS – Princess Margaret Cancer Centre

  • 2:30 PM – 2:40 PM PT
    LBA 01 - Randomized Phase III Trial of Postoperative Radiotherapy with or without Cetuximab for Intermediate-Risk Squamous Cell Carcinoma of the Head and Neck (SCCHN): NRG/RTOG 0920
    Location: Ballroom 20

    Presenter: Mitchell Machtay, MD, FASTRO – Penn State Hershey Medical Center

  • 2:40 PM – 2:50 PM PT
    LBA 02 - Randomized Controlled Trial of Hypofractionated vs. Normo-fractionated Accelerated Radiation Therapy with or without Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma (HYPNO)
    Location: Ballroom 20

    Presenter: Soren Bentzen, DSc, PhD, FASTRO – University of Maryland School of Medicine

  • 2:50 PM – 3:00 PM PT
    Discussant
    Location: Ballroom 20

    Discussant: Christina Chapman, MD, MS – Baylor College of Medicine

  • 3:00 PM – 3:07 PM PT
    157 - Peripheral T-Cell Priming and Micrometastatic Disease Control with Metastasis-Directed Therapy: Multidimensional Immunogenomic Profiling of Oligometastatic Prostate Cancer in the EXTEND Trial
    Location: Room 6 D/E

    Presenter: Alexander Sherry, MD – University of Texas MD Anderson Cancer Center

  • 3:10 PM – 3:17 PM PT
    158 - Validation of a Genomic Classifier in the NRG Oncology/RTOG 0521 Phase III Trial of Docetaxel with Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer
    Location: Room 6 D/E

    Presenter: Ryan Phillips, MD, PhD – The Mayo Clinic

  • 3:20 PM – 3:27 PM PT
    159 - Cross-Comparison Individual Patient Level Analysis of Three Gene Expression Signatures in Localized Prostate in over 50,000 Men
    Location: Room 6 D/E

    Presenter: Angela Jia, MD, PhD – Case Western Reserve University/University Hospitals Cleveland Medical Center

  • 3:30 PM – 3:37 PM PT
    160 - Detection Rate of 18F-rhPSMA-7.3 PET in Patients with Suspected Prostate Cancer Recurrence at PSA Levels <1 ng/mL: Data from the Phase 3 SPOTLIGHT Study
    Location: Room 6 D/E

    Presenter: Ashesh Jani, MD, FASTRO – Emory University

  • 3:40 PM – 3:47 PM PT
    161 - PSMA-Positive Extracellular Vesicles Predict Disease Recurrence in Oligometastatic Castration-Sensitive Prostate Cancer Treated with Stereotactic Ablative Radiotherapy: Analysis of the ORIOLE trial
    Location: Room 6 D/E

    Presenter: Edlira Horjeti, MD, MBBS – Mayo Clinic

  • 3:50 PM – 4:00 PM PT
    Discussant
    Location: Room 6 D/E

    Discussant: Osama Mohamad, MD, PhD – MD Anderson Cancer Center

  • 3:00 PM – 3:07 PM PT
    173 - Combination of BET Inhibition with Radiation Induces Anti-Tumor Immune Response in Pre-Clinical Models of ER-Positive Breast Cancer
    Location: Room 30 D/E

    Presenter: Prasanna Alluri, MD, PhD – UT Southwestern Medical Center at Dallas

  • 3:10 PM – 3:17 PM PT
    174 - CRISPR-Based Epigenome Editing and Genome Wide Screening Define Mediators of Chemotherapy Response in Glioblastoma
    Location: Room 30 D/E

    Presenter: S. John Liu, MD, PhD – UCSF

  • 3:20 PM – 3:27 PM PT
    175 - In Silico Discovery and Investigation of Novel Small Molecules Targeting PSMA7 for the Treatment of GBM
    Location: Room 30 D/E

    Presenter: Christian Showalter, PhD – The Ohio State University

  • 3:30 PM – 3:37 PM PT
    176 - Targeting Tri-Methyl-Histone H3 (Lys27) in Rectal Cancer: A Novel Strategy to Enhance Radiosensitivity and Predict Response to Neoadjuvant Therapy
    Location: Room 30 D/E

    Presenter: Anam Kesaria, MD – UAMS Radiation Oncology

  • 3:40 PM – 3:47 PM PT
    177 - Targeting Non-Kinase Function of CDK6 to Overcome CDK4/6 Inhibitor Resistance
    Location: Room 30 D/E

    Presenter: Prasanna Alluri, MD, PhD – UT Southwestern Medical Center at Dallas

  • 3:50 PM – 3:57 PM PT
    178 - Nanobody-Based ImmunoPET for Hepatocellular Carcinoma
    Location: Room 30 D/E

    Presenter: Stanley Fayn, BS – National Cancer Institute

  • 3:00 PM – 3:07 PM PT
    168 - Short Course Adjuvant Vaginal Cuff Brachytherapy (VCB) in Early Endometrial Cancer: Primary Endpoint Results of the SAVE Randomized Clinical Trial
    Location: Room 31

    Presenter: Gita Suneja, MD, MS – University of Utah Huntsman Cancer Institute

  • 3:10 PM – 3:17 PM PT
    169 - Toripalimab Combined with Chemoradiotherapy for Locally Advanced Cervical Squamous Cell Carcinoma Patients: Early Results of Safety and Feasibility
    Location: Room 31

    Presenter: Dan Ou, MD

  • 3:20 PM – 3:27 PM PT
    170 - Evaluating the Effects of Bone Marrow Sparing Radiotherapy on Acute Hematologic Toxicity for Patients with Locoregionally Advanced Cervical Cancer: A Prospective Phase II Randomized Controlled Trial
    Location: Room 31

    Presenter: Wen Li, PhD candidate – West China Second University Hospital

  • 3:30 PM – 3:37 PM PT
    171 - HYPOCx-iRex (TCTR20210812003) A Phase II RCT: 44Gy/20F VS 45Gy/25F CCRT in Cervical Cancer - 6-mo Post-RT Update
    Location: Room 31

    Presenter: Tissana Prasartseree, MD – Siriraj Hospital Mahidol University

  • 3:40 PM – 3:47 PM PT
    172 - Multiple Sessions vs. Single Session Image-Based Intracavitary Brachytherapy for Locally Advanced Cervical Cancer - A Randomized Control Trial
    Location: Room 31

    Presenter: Daya Nand Sharma, MD, PhD – AIIMS New Delhi

  • 3:48 PM – 3:58 PM PT
    Discussant
    Location: Room 31

    Discussant: Katherine Tzou, MD – University of Colorado Anschutz Medical Campus

  • 3:00 PM – 3:07 PM PT
    162 - Radiochemical Oxygen Depletion Depends on Chemical Environment and Dose-Rate: Implications for FLASH Effect
    Location: Room 30 A/B/C

    Presenter: Rodney Wiersma, PhD – University of Pennsylvania

  • 3:10 PM – 3:17 PM PT
    163 - A Novel Planning and Delivery Technology: Dose, Dose Rate and Linear Energy Transfer(LET) Optimization Based on Spot-Scanning Proton Arc Therapy FLASH (SPLASHLET)
    Location: Room 30 A/B/C

    Presenter: Gang Liu, PhD – Beaumont Health System

  • 3:10 PM – 3:17 PM PT
    163 - A Novel Planning and Delivery Technology: Dose, Dose Rate and Linear Energy Transfer(LET) Optimization Based on Spot-Scanning Proton Arc Therapy FLASH (SPLASHLET)
    Location: Room 30 A/B/C

    Presenter: Xiaoqiang Li, PhD – William Beaumont Hospital

  • 3:20 PM – 3:27 PM PT
    164 - An Effective Dose Rate Optimization Algorithm for Efficient Conventional-Dose-Rate Proton Therapy and Ultra-High-Dose-Rate FLASH Proton Therapy
    Location: Room 30 A/B/C

    Presenter: Yuting Lin, PhD – University of Kansas Medical Center

  • 3:30 PM – 3:37 PM PT
    165 - Towards Clinical Proton Minibeam Radiation Therapy (pMBRT): Development of Clinical pMBRT System Prototype and pMBRT-Specific Treatment Planning Method
    Location: Room 30 A/B/C

    Presenter: Hao Gao, PhD – University of Kansas Medical Center

  • 3:40 PM – 3:47 PM PT
    166 - Towards Clinical Translation of Microbeam Radiation Therapy (MRT) with a Compact Source
    Location: Room 30 A/B/C

    Presenter: Stefan Bartzsch, PhD

  • 3:50 PM – 3:57 PM PT
    167 - Spot Scanning Proton Therapy for Pregnant Patients with Brain and Head and Neck Tumors
    Location: Room 30 A/B/C

    Presenter: Justine Dupere, PhD – Mayo Clinic

  • 3:05 PM – 3:10 PM PT
    1060 - Implementation Outcomes of Strategies to Promote Short-Course Radiation for Nonspine Bone Metastases in an Academic-Community Partnership: Survey Results from the ALIGNMENT Trial
    Location: Room 8

    Presenter: Patricia Santos, MD, MS – Memorial Sloan Kettering Cancer Center

  • 3:15 PM – 3:20 PM PT
    1064 - Patient and Caregivers Opinions on Receiving Radiology Results before Oncologist Appointments
    Location: Room 8

    Presenter: Nicholas Eustace, MD, PhD, BS – City of Hope National Medical Center

  • 3:20 PM – 3:25 PM PT
    1066 - Do Physician Patient Sharing Networks Impact Disparities in Access to Multidisciplinary Cancer Consultation for Early Stage Lung Cancer? A SEER-Medicare Network Analysis
    Location: Room 8

    Presenter: Nirav Kapadia, MD, MS – Dartmouth-Hitchcock Medical Center

  • 3:25 PM – 3:30 PM PT
    1068 - Multi-Institutional Fact-Finding Study: Association between Geriatric Assessment and Reduction in Intensity of Radiotherapy for Elderly Cancer Patients without Metastasis
    Location: Room 8

    Presenter: Keiko Murofushi, MD, PhD – Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

  • 3:30 PM – 3:35 PM PT
    1070 - Radiotherapy Access and Treatment in Rwanda: Demographics and Clinical Characteristics of Cervical Cancer Patients
    Location: Room 8

    Presenter: Timothy Davis, BS – Albert Einstein College of Medicine

  • 5:00 PM – 5:07 PM PT
    179 - Is it the Type of Axillary Surgery or the Number of Removed Lymph Nodes That Increases the Risk of Breast Cancer Related Lymphedema (BCRL)? Results from a Prospective Screening Trial
    Location: Room 6 C/F

    Presenter: George Naoum, MD, MS – Massachusetts General Hospital

  • 5:09 PM – 5:16 PM PT
    180 - Increased Complication Rates with Proton Therapy in Breast Cancer Patients with Immediate, Implant-Based Reconstruction: Single-Institution Comparative Effectiveness Analysis
    Location: Room 6 C/F

    Presenter: Alphonse Taghian, MD, PhD, FASTRO – Massachusetts General Hospital

  • 5:18 PM – 5:25 PM PT
    181 - Risk of Radiation-Associated Secondary Malignancies Among Patients with Breast Cancer Harboring TP53 Germline Variants
    Location: Room 6 C/F

    Presenter: Gustav Cederquist, MD, PhD – Memorial Sloan Kettering Cancer Center

  • 5:27 PM – 5:34 PM PT
    182 - Early Results of the French Multicenter, Randomized SHARE Trial Comparing Whole Breast Irradiation vs. Accelerated Partial Breast Irradiation in Postmenopausal Women with Early-Stage Breast Cancer
    Location: Room 6 C/F

    Presenter: Yazid Belkacemi, MD, PhD – Henri Mondor University Hospital and Faculte de Medecin de Creteil Paris XII

  • 5:36 PM – 5:43 PM PT
    183 - Comparison between Pre-Pectoral and Post-Pectoral Implant Reconstruction and Different Radiation Modalities on Breast Reconstruction Complications
    Location: Room 6 C/F

    Presenter: George Naoum, MD, MS – Massachusetts General Hospital

  • 5:45 PM – 5:52 PM PT
    184 - Effectiveness and Toxicity of Five Fraction Prone Accelerated Partial Breast Irradiation
    Location: Room 6 C/F

    Presenter: Camille Hardy Abeloos, MD – NYU Grossman School of Medicine

  • 5:54 PM – 5:58 PM PT
    Discussant
    Location: Room 6 C/F

    Discussant: Rachel Rabinovitch, MD, FASTRO – University of Colorado Denver

  • 5:54 PM – 6:00 PM PT
    Discussant
    Location: Room 6 C/F

    Discussant: Jean Wright, MD, FASTRO – Johns Hopkins University

  • 5:00 PM – 5:07 PM PT
    191 - Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphomas: An ILROG Multi-Institutional Study
    Location: Room 31

    Presenter: Nikhil Yegya-Raman, MD – University of Pennsylvania Health System

  • 5:10 PM – 5:17 PM PT
    192 - Phase I Trial of Re-Priming Radiation Therapy for Relapsed/Refractory Non-Hodgkin Lymphoma Patients in Incomplete Response after Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
    Location: Room 31

    Presenter: Kiran Kumar, MD, MBA – UT Southwestern Medical Center

  • 5:20 PM – 5:27 PM PT
    193 - Consolidative Radiotherapy for Residual PET-Avid Disease on Day +30 Post CAR T-Cell Therapy in Non-Hodgkin Lymphoma
    Location: Room 31

    Presenter: Omran Saifi, MD – Mayo Clinic Florida

  • 5:30 PM – 5:37 PM PT
    194 - Prognostic Significance of Positron Emission Tomography Delta Radiomics Following Bridging Therapy in Patients with Large B-Cell Lymphoma Undergoing CAR T-Cell Therapy
    Location: Room 31

    Presenter: Colton Ladbury, MD, BS – City of Hope National Medical Center

  • 5:40 PM – 5:47 PM PT
    195 - Characterization of Lymphopenia during Bridging Radiation Therapy Prior to CAR-T Cell Therapy in Patients with Aggressive B Cell Lymphomas
    Location: Room 31

    Presenter: Gohar Manzar, MD, PhD – MD Anderson Cancer Center

  • 5:50 PM – 6:00 PM PT
    Discussant
    Location: Room 31

    Discussant: Timothy Robinson, MD, PhD – Yale Therapeutic Radiology

  • 5:00 PM – 5:07 PM PT
    185 - Real Time Volumetric MRI for MR-Guided 3D Motion Tracking via Sparse Prior-Augmented Neural Representation Learning
    Location: Room 1

    Presenter: Lianli Liu, PhD – Stanford University

  • 5:10 PM – 5:17 PM PT
    186 - Heatmaps to Assess Tumor Motion Probability with MRcine in Head and Neck Cancer
    Location: Room 1

    Presenter: Yonatan Weiss, MD – Miami Cancer Institute

  • 5:20 PM – 5:27 PM PT
    187 - Principal Component Analysis to Design Planning Target Volume in Oropharyngeal Cancers
    Location: Room 1

    Presenter: Mona Arbab, MD, M.Ed – UT Southwestern Medical Center

  • 5:30 PM – 5:37 PM PT
    188 - Reduction of Late Urinary Toxicity from Prostate Cancer Radiotherapy via Intrafractional MV-kV Image Guidance
    Location: Room 1

    Presenter: Pengpeng Zhang, PhD – Memorial Sloan Kettering Cancer Center

  • 5:40 PM – 5:47 PM PT
    189 - Deep Learning-Based Single-View Fluorescence Dose Reconstruction for 3D Dosimetry
    Location: Room 1

    Presenter: Yusuke Nomura, PhD – Stanford University

  • 5:50 PM – 5:57 PM PT
    190 - Deep Learning-Based Automated Quality Assurance for Palliative Spinal Treatment Planning in Radiotherapy
    Location: Room 1

    Presenter: Christopher Kehayias, PhD – Brigham and Women's Hospital/Dana-Farber

  • 5:05 PM – 5:10 PM PT
    1072 - PD-L1 Inhibitors Combined with Thoracic Radiotherapy in First-Line Treatment of Extensive Stage Small Cell Lung Cancer: A Propensity Score-Matched, Real-World Study
    Location: Room 8

    Presenter: Jianfeng Peng, PhD

  • 5:10 PM – 5:15 PM PT
    1074 - Progression-Free Survival As a Surrogate Endpoint of Overall Survival in Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy: Trial-Level Meta-Analysis and Individ
    Location: Room 8

    Presenter: Chen Hu, PhD – Johns Hopkins University

  • 5:15 PM – 5:20 PM PT
    1076 - Early Stereotactic Body Radiotherapy to the Primary Lung Lesion for Patients with Advanced NSCLC Treated with First-Line Systemic Therapy
    Location: Room 8

    Presenter: Dan Tao, MD – Chongqing University Cancer Hospital

  • 5:20 PM – 5:25 PM PT
    1078 - Treatment Efficacy Outcomes Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Survival Analysis of a Phase IB trial
    Location: Room 8

    Presenter: Brett Morris, MD, PhD – University of Wisconsin

  • 5:25 PM – 5:30 PM PT
    1080 - Genomic Signature for Oligometastatic Disease in Non-Small Cell Lung Cancer Patients with Brain Metastases
    Location: Room 8

    Presenter: Ariel Choi, MD – Wake Forest Baptist Medical Center

  • 5:00 PM – 6:00 PM PT
    2599 - Determining the Minimal Clinically Important Difference of the FACT-E to Evaluate the Change in the Quality of Life of Patients with Esophageal Cancer Treated with Curative Radiotherapy
    Location: Hall B1

    Presenter: Isabella Zaniletti, PhD – IZ Statistics LLC